the answers , page-31

PC is a scientist who is surrounded, predominantly, by more scientists.

Okay, this is a drug development company, so a big part of it is about the drugs they develop, but a key part of it is getting the optimal commercial return for their discoveries.

They have failed in this regard with Relenza and as for LANI, only time will tell. HRV is next. They don't pump these potential blockbusters out every year, so chances are limited.

Are we prepared to give Peter the benefit of the doubt in terms of his commercial credentials? Well that's where we are at right now.

I'd like to see a person with Business runs on the board aggressively driving this company forward...no mincing around anymore. There are enough scientific people doing the right thing behind the scenes at Biota.